Discovery of Novel Irreversible HER2 Inhibitors for Breast Cancer Treatment

Journals Menu

Follow SCIRP

ISSN Print: 1937-6871
ISSN Online: 1937-688X
www.scirp.org/journal/jbise
E-mail: jbise@scirp.org

"Discovery of Novel Irreversible HER2 Inhibitors for Breast Cancer Treatment"
written by Jhih-Yan Tang, Yih Ho, Chun-Yi Chang, Hsuan-Liang Liu,
published by Journal of Biomedical Science and Engineering, Vol.12 No.4, 2019

has been cited by the following article(s):

[1]	Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer
	Breast Disease, 2021

[2]	Signaling pathways governing breast cancer stem cells behavior
	2021

[1]	Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer Breast Disease, 2021 DOI:10.3233/BD-201063

[2]	Signaling pathways governing breast cancer stem cells behavior Stem Cell Research & Therapy, 2021 DOI:10.1186/s13287-021-02321-w

[3]	Signaling pathways governing breast cancer stem cells behavior Stem Cell Research & Therapy, 2021 DOI:10.1186/s13287-021-02321-w

Follow SCIRP